NCT00382226View on ClinicalTrials.gov

IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Glaucoma
Interventions
DRUG

Azopt

Trial Locations (1)

2000

Sydney Study Site, Sydney

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00382226 - IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy | Biotech Hunter | Biotech Hunter